China Medical System Price Prediction

CHSYFDelisted Stock  USD 0.93  0.00  0.00%   
As of 1st of February 2025 the relative strength index (rsi) of China Medical's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of China Medical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of China Medical and does not consider all of the tangible or intangible factors available from China Medical's fundamental data. We analyze noise-free headlines and recent hype associated with China Medical System, which may create opportunities for some arbitrage if properly timed.
Using China Medical hype-based prediction, you can estimate the value of China Medical System from the perspective of China Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in China Medical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying China because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

China Medical after-hype prediction price

    
  USD 0.93  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.790.791.02
Details
Naive
Forecast
LowNextHigh
0.930.930.93
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.930.930.93
Details

China Medical After-Hype Price Prediction Density Analysis

As far as predicting the price of China Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of China Medical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

China Medical Estimiated After-Hype Price Volatility

In the context of predicting China Medical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China Medical's historical news coverage. China Medical's after-hype downside and upside margins for the prediction period are 0.93 and 0.93, respectively. We have considered China Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.93
0.93
After-hype Price
0.93
Upside
China Medical is very steady at this time. Analysis and calculation of next after-hype price of China Medical System is based on 3 months time horizon.

China Medical Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as China Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China Medical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
5 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.93
0.93
0.00 
0.00  
Notes

China Medical Hype Timeline

China Medical System is currently traded for 0.93. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. China is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on China Medical is about 0.0%, with the expected price after the next announcement by competition of 0.93. About 50.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Medical System last dividend was issued on the 6th of September 2022. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

China Medical Related Hype Analysis

Having access to credible news sources related to China Medical's direct competition is more important than ever and may enhance your ability to predict China Medical's future price movements. Getting to know how China Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China Medical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
TAIPYTaisho Pharmaceutical Holdings 0.00 0 per month 1.40 (0.03) 0.00 (0.78) 16.67 
ESAIYEisai Co 0.00 0 per month 0.00 (0.16) 1.98 (2.61) 10.69 
RDYDr Reddys Laboratories(0.05)8 per month 0.00 (0.15) 2.14 (2.57) 10.27 
ANIPANI Pharmaceuticals 0.14 8 per month 1.90 (0.04) 3.04 (3.64) 9.65 
LNTHLantheus Holdings 1.97 9 per month 0.00 (0.08) 4.00 (4.96) 27.61 
CRONCronos Group(0.02)8 per month 0.00 (0.09) 3.35 (3.65) 19.33 
EVRRFMolecule Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
GNMLFGenomma Lab Internacional 0.00 0 per month 0.00  0.11  0.00  0.00  12.39 
BCBCFThe BC Bud 0.00 0 per month 5.63  0.19  39.37 (13.07) 425.33 
BIOIFBiome Grow 0.00 0 per month 0.00 (0.01) 0.00 (48.65) 263.16 
WIBFFWest Island Brands 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MNKMallinckrodt Plc(0.04)2 per month 13.99  0.03  12.50 (30.95) 504.19 
SNDLSNDL Inc 0.05 7 per month 0.00 (0.09) 4.17 (3.60) 24.46 
HKMPFHikma Pharmaceuticals PLC 0.00 0 per month 0.00  0  2.09 (1.72) 11.72 
TEVATeva Pharma Industries(0.51)10 per month 3.32 (0.01) 3.66 (3.67) 40.36 

China Medical Additional Predictive Modules

Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About China Medical Predictive Indicators

The successful prediction of China Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as China Medical System, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of China Medical based on analysis of China Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to China Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to China Medical's related companies.

Story Coverage note for China Medical

The number of cover stories for China Medical depends on current market conditions and China Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

China Medical Short Properties

China Medical's future price predictability will typically decrease when China Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China Medical System often depends not only on the future outlook of the potential China Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.5 B
Short Long Term Debt1.1 B
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in China Pink Sheet

If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.